A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies
Clinical trial NCT07107204 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07107204
- Sponsor
- Biotroy Therapeutics
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-01
- Primary completion
- 2028-01-01
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.